Review




Structured Review

Addgene inc ori neg
Ori Neg, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ori+neg/STARR-seq+luciferase+validation+vector_ORI_neg%2Econt+(Plasmid+%2399315)/10__1158_slash_2643___3230__bcd___24___0126-375-5-7
Average 93 stars, based on 4 article reviews
ori neg - by Bioz Stars, 2026-10
93/100 stars

Images

Related Articles

other:

Article Title: Selective Enhancer Dependencies in MYC-Intact and MYC-Rearranged Germinal Center B-cell Diffuse Large B-cell Lymphoma
Article Snippet: Vectors ORI_SV40 (RRID: Addgene_99309) and ORI_neg.cont (RRID: Addgene_99315) were used as positive and negative controls.

Article Title: Selective Enhancer Dependencies in MYC-Intact and MYC-Rearranged Germinal Center B-cell Diffuse Large B-cell Lymphoma
Article Snippet: We modified the NFR195B clone via site-directed mutagenesis (Q5 SDM kit E0554S; NEB) to delete the indicated OCT2-binding motif (“TTTGCAT”) and to generate the patientderived mutant allele from DLBCL 14-35632 (hg38 chr8:128172453_ T>C/chr8:128172455_G>GA).



Similar Products

93
Addgene inc ori neg
Ori Neg, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ori+neg/STARR-seq+luciferase+validation+vector_ORI_neg%2Econt+(Plasmid+%2399315)/10__1158_slash_2643___3230__bcd___24___0126-375-5-7
Average 93 stars, based on 1 article reviews
ori neg - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
Addgene inc vectors ori sv40
A. Heatmap showing differential acetylation of enhancer clusters with increased acetylation in GCB-DLBCL cell lines. MYC rearrangement status is coded as follows: white, no rearrangement; gray, positive for MYC::BCL6-SE rearrangement; black, positive for other MYC rearrangement. Heatmaps strips at right show significance of motif enrichment for the OCT2 and E2A ( TCF3 ) motifs in HOMER known motif analysis; black arrowheads indicate that a similar motif was identified as the most significantly enriched motif in that cluster by de novo motif analysis. See Supplementary Figures 5B-C for the corresponding data for all enhancer clusters and all cell lines. B. Western blot of nuclear extracts from GCB-DLBCL cell lines for MEF2B and CTCF (loading control). C. Genomic copy gains (log scale) for POU2AF1 in B-cell lymphoma cell lines (DepMap). GCBME-1-dependent cell lines are indicated. D. POU2F2 and POU2AF1 transcript levels in B-cell lymphoma cell lines (DepMap). GCBME-1-dependent cell lines are indicated. E. Plot of sgRNA depletion or enrichment (MAGeCK RRA log2-fold-change) for optimized gene promoter-targeting sgRNAs in lymphoma CRISPRi screens (B cell expressed transcription factors, B-cell-specific essential genes, and pan-essential genes). Target intervals are ranked along the X axis by lowest negative selection FDR p-value (left to right, intervals with log2-fold change <0) or lowest positive selection FDR p-value (right to left, intervals with log2-fold change >0). Genes with abs(log2FC) > 0.5 and fdr < 0.05 are colored blue. TF genes of interest are indicated. F. Detail of ATAC-Seq, H3K27 ChIP-Seq, and ChIP-Seq for the OCT2, OCA-B, MEF2B, and p300 in the GCBME1 enhancer cluster. CRISPRi screen NFR intervals are as indicated, with conserved subregions A and B of NFRs 195 and 196 indicated below. Inset at bottom shows further detail of the Phastcons conserved element track for sub-region 195B (see Supplementary Figure 5G for further detail), with the position of the conserved OCT2 motif indicated. G. Change in MYC expression (qRT-PCR) in GCBME1-dependent DLBCL cell lines expressing doxycycline-inducible dCas9-KRAB after transduction with indicated sgRNAs targeting MEF2B, POU2F2, and POU2AF1 (**** p<0.0001, *** p<0.001, ** p<0.01, * p<0.01, t-test of pooled replicates for both TF gene promoter-targeting sgRNAs versus both control sgRNAs, color-coded by measured transcript per legend). H. Transcriptional reporter assay in SUDHL-5 cells for sub-regions of the GCBME-1 cloned into the <t>STARR-Seq_Ori</t> luciferase vector. Firefly luciferase signal for each sample was normalized to internal transfection control (Renilla luciferase signal) and then to the normalized signal for the no-insert control vector <t>(Ori_neg).</t> I. Transcriptional reporter assay in the indicated GCBME-1-dependent cell lines for constructs bearing the NFR 195B enhancer region, with or without OCT2 motif deletion, normalized as in H.
Vectors Ori Sv40, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ori+neg/STARR-seq+luciferase+validation+vector_ORI_neg%2Econt+(Plasmid+%2399315)/bio_rxiv__2023__05__02__538892-42-0-5
Average 93 stars, based on 1 article reviews
vectors ori sv40 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
Addgene inc starr seq luciferase validation vector
A. Heatmap showing differential acetylation of enhancer clusters with increased acetylation in GCB-DLBCL cell lines. MYC rearrangement status is coded as follows: white, no rearrangement; gray, positive for MYC::BCL6-SE rearrangement; black, positive for other MYC rearrangement. Heatmaps strips at right show significance of motif enrichment for the OCT2 and E2A ( TCF3 ) motifs in HOMER known motif analysis; black arrowheads indicate that a similar motif was identified as the most significantly enriched motif in that cluster by de novo motif analysis. See Supplementary Figures 5B-C for the corresponding data for all enhancer clusters and all cell lines. B. Western blot of nuclear extracts from GCB-DLBCL cell lines for MEF2B and CTCF (loading control). C. Genomic copy gains (log scale) for POU2AF1 in B-cell lymphoma cell lines (DepMap). GCBME-1-dependent cell lines are indicated. D. POU2F2 and POU2AF1 transcript levels in B-cell lymphoma cell lines (DepMap). GCBME-1-dependent cell lines are indicated. E. Plot of sgRNA depletion or enrichment (MAGeCK RRA log2-fold-change) for optimized gene promoter-targeting sgRNAs in lymphoma CRISPRi screens (B cell expressed transcription factors, B-cell-specific essential genes, and pan-essential genes). Target intervals are ranked along the X axis by lowest negative selection FDR p-value (left to right, intervals with log2-fold change <0) or lowest positive selection FDR p-value (right to left, intervals with log2-fold change >0). Genes with abs(log2FC) > 0.5 and fdr < 0.05 are colored blue. TF genes of interest are indicated. F. Detail of ATAC-Seq, H3K27 ChIP-Seq, and ChIP-Seq for the OCT2, OCA-B, MEF2B, and p300 in the GCBME1 enhancer cluster. CRISPRi screen NFR intervals are as indicated, with conserved subregions A and B of NFRs 195 and 196 indicated below. Inset at bottom shows further detail of the Phastcons conserved element track for sub-region 195B (see Supplementary Figure 5G for further detail), with the position of the conserved OCT2 motif indicated. G. Change in MYC expression (qRT-PCR) in GCBME1-dependent DLBCL cell lines expressing doxycycline-inducible dCas9-KRAB after transduction with indicated sgRNAs targeting MEF2B, POU2F2, and POU2AF1 (**** p<0.0001, *** p<0.001, ** p<0.01, * p<0.01, t-test of pooled replicates for both TF gene promoter-targeting sgRNAs versus both control sgRNAs, color-coded by measured transcript per legend). H. Transcriptional reporter assay in SUDHL-5 cells for sub-regions of the GCBME-1 cloned into the <t>STARR-Seq_Ori</t> luciferase vector. Firefly luciferase signal for each sample was normalized to internal transfection control (Renilla luciferase signal) and then to the normalized signal for the no-insert control vector <t>(Ori_neg).</t> I. Transcriptional reporter assay in the indicated GCBME-1-dependent cell lines for constructs bearing the NFR 195B enhancer region, with or without OCT2 motif deletion, normalized as in H.
Starr Seq Luciferase Validation Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ori+neg/STARR-seq+luciferase+validation+vector_ORI_neg%2Econt+(Plasmid+%2399315)/pm36113676-99-30-34
Average 93 stars, based on 1 article reviews
starr seq luciferase validation vector - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
Addgene inc control
A. Heatmap showing differential acetylation of enhancer clusters with increased acetylation in GCB-DLBCL cell lines. MYC rearrangement status is coded as follows: white, no rearrangement; gray, positive for MYC::BCL6-SE rearrangement; black, positive for other MYC rearrangement. Heatmaps strips at right show significance of motif enrichment for the OCT2 and E2A ( TCF3 ) motifs in HOMER known motif analysis; black arrowheads indicate that a similar motif was identified as the most significantly enriched motif in that cluster by de novo motif analysis. See Supplementary Figures 5B-C for the corresponding data for all enhancer clusters and all cell lines. B. Western blot of nuclear extracts from GCB-DLBCL cell lines for MEF2B and CTCF (loading control). C. Genomic copy gains (log scale) for POU2AF1 in B-cell lymphoma cell lines (DepMap). GCBME-1-dependent cell lines are indicated. D. POU2F2 and POU2AF1 transcript levels in B-cell lymphoma cell lines (DepMap). GCBME-1-dependent cell lines are indicated. E. Plot of sgRNA depletion or enrichment (MAGeCK RRA log2-fold-change) for optimized gene promoter-targeting sgRNAs in lymphoma CRISPRi screens (B cell expressed transcription factors, B-cell-specific essential genes, and pan-essential genes). Target intervals are ranked along the X axis by lowest negative selection FDR p-value (left to right, intervals with log2-fold change <0) or lowest positive selection FDR p-value (right to left, intervals with log2-fold change >0). Genes with abs(log2FC) > 0.5 and fdr < 0.05 are colored blue. TF genes of interest are indicated. F. Detail of ATAC-Seq, H3K27 ChIP-Seq, and ChIP-Seq for the OCT2, OCA-B, MEF2B, and p300 in the GCBME1 enhancer cluster. CRISPRi screen NFR intervals are as indicated, with conserved subregions A and B of NFRs 195 and 196 indicated below. Inset at bottom shows further detail of the Phastcons conserved element track for sub-region 195B (see Supplementary Figure 5G for further detail), with the position of the conserved OCT2 motif indicated. G. Change in MYC expression (qRT-PCR) in GCBME1-dependent DLBCL cell lines expressing doxycycline-inducible dCas9-KRAB after transduction with indicated sgRNAs targeting MEF2B, POU2F2, and POU2AF1 (**** p<0.0001, *** p<0.001, ** p<0.01, * p<0.01, t-test of pooled replicates for both TF gene promoter-targeting sgRNAs versus both control sgRNAs, color-coded by measured transcript per legend). H. Transcriptional reporter assay in SUDHL-5 cells for sub-regions of the GCBME-1 cloned into the <t>STARR-Seq_Ori</t> luciferase vector. Firefly luciferase signal for each sample was normalized to internal transfection control (Renilla luciferase signal) and then to the normalized signal for the no-insert control vector <t>(Ori_neg).</t> I. Transcriptional reporter assay in the indicated GCBME-1-dependent cell lines for constructs bearing the NFR 195B enhancer region, with or without OCT2 motif deletion, normalized as in H.
Control, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ori+neg/STARR-seq+luciferase+validation+vector_ORI_neg%2Econt+(Plasmid+%2399315)/pm32442405-458-51-52
Average 93 stars, based on 1 article reviews
control - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
Addgene inc negative control vector addgene
A. Heatmap showing differential acetylation of enhancer clusters with increased acetylation in GCB-DLBCL cell lines. MYC rearrangement status is coded as follows: white, no rearrangement; gray, positive for MYC::BCL6-SE rearrangement; black, positive for other MYC rearrangement. Heatmaps strips at right show significance of motif enrichment for the OCT2 and E2A ( TCF3 ) motifs in HOMER known motif analysis; black arrowheads indicate that a similar motif was identified as the most significantly enriched motif in that cluster by de novo motif analysis. See Supplementary Figures 5B-C for the corresponding data for all enhancer clusters and all cell lines. B. Western blot of nuclear extracts from GCB-DLBCL cell lines for MEF2B and CTCF (loading control). C. Genomic copy gains (log scale) for POU2AF1 in B-cell lymphoma cell lines (DepMap). GCBME-1-dependent cell lines are indicated. D. POU2F2 and POU2AF1 transcript levels in B-cell lymphoma cell lines (DepMap). GCBME-1-dependent cell lines are indicated. E. Plot of sgRNA depletion or enrichment (MAGeCK RRA log2-fold-change) for optimized gene promoter-targeting sgRNAs in lymphoma CRISPRi screens (B cell expressed transcription factors, B-cell-specific essential genes, and pan-essential genes). Target intervals are ranked along the X axis by lowest negative selection FDR p-value (left to right, intervals with log2-fold change <0) or lowest positive selection FDR p-value (right to left, intervals with log2-fold change >0). Genes with abs(log2FC) > 0.5 and fdr < 0.05 are colored blue. TF genes of interest are indicated. F. Detail of ATAC-Seq, H3K27 ChIP-Seq, and ChIP-Seq for the OCT2, OCA-B, MEF2B, and p300 in the GCBME1 enhancer cluster. CRISPRi screen NFR intervals are as indicated, with conserved subregions A and B of NFRs 195 and 196 indicated below. Inset at bottom shows further detail of the Phastcons conserved element track for sub-region 195B (see Supplementary Figure 5G for further detail), with the position of the conserved OCT2 motif indicated. G. Change in MYC expression (qRT-PCR) in GCBME1-dependent DLBCL cell lines expressing doxycycline-inducible dCas9-KRAB after transduction with indicated sgRNAs targeting MEF2B, POU2F2, and POU2AF1 (**** p<0.0001, *** p<0.001, ** p<0.01, * p<0.01, t-test of pooled replicates for both TF gene promoter-targeting sgRNAs versus both control sgRNAs, color-coded by measured transcript per legend). H. Transcriptional reporter assay in SUDHL-5 cells for sub-regions of the GCBME-1 cloned into the <t>STARR-Seq_Ori</t> luciferase vector. Firefly luciferase signal for each sample was normalized to internal transfection control (Renilla luciferase signal) and then to the normalized signal for the no-insert control vector <t>(Ori_neg).</t> I. Transcriptional reporter assay in the indicated GCBME-1-dependent cell lines for constructs bearing the NFR 195B enhancer region, with or without OCT2 motif deletion, normalized as in H.
Negative Control Vector Addgene, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ori+neg/STARR-seq+luciferase+validation+vector_ORI_empty+(Plasmid+%2399297)/pm32442405-263-12-15
Average 93 stars, based on 1 article reviews
negative control vector addgene - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
Addgene inc starr seq plasmid sequence
A. Heatmap showing differential acetylation of enhancer clusters with increased acetylation in GCB-DLBCL cell lines. MYC rearrangement status is coded as follows: white, no rearrangement; gray, positive for MYC::BCL6-SE rearrangement; black, positive for other MYC rearrangement. Heatmaps strips at right show significance of motif enrichment for the OCT2 and E2A ( TCF3 ) motifs in HOMER known motif analysis; black arrowheads indicate that a similar motif was identified as the most significantly enriched motif in that cluster by de novo motif analysis. See Supplementary Figures 5B-C for the corresponding data for all enhancer clusters and all cell lines. B. Western blot of nuclear extracts from GCB-DLBCL cell lines for MEF2B and CTCF (loading control). C. Genomic copy gains (log scale) for POU2AF1 in B-cell lymphoma cell lines (DepMap). GCBME-1-dependent cell lines are indicated. D. POU2F2 and POU2AF1 transcript levels in B-cell lymphoma cell lines (DepMap). GCBME-1-dependent cell lines are indicated. E. Plot of sgRNA depletion or enrichment (MAGeCK RRA log2-fold-change) for optimized gene promoter-targeting sgRNAs in lymphoma CRISPRi screens (B cell expressed transcription factors, B-cell-specific essential genes, and pan-essential genes). Target intervals are ranked along the X axis by lowest negative selection FDR p-value (left to right, intervals with log2-fold change <0) or lowest positive selection FDR p-value (right to left, intervals with log2-fold change >0). Genes with abs(log2FC) > 0.5 and fdr < 0.05 are colored blue. TF genes of interest are indicated. F. Detail of ATAC-Seq, H3K27 ChIP-Seq, and ChIP-Seq for the OCT2, OCA-B, MEF2B, and p300 in the GCBME1 enhancer cluster. CRISPRi screen NFR intervals are as indicated, with conserved subregions A and B of NFRs 195 and 196 indicated below. Inset at bottom shows further detail of the Phastcons conserved element track for sub-region 195B (see Supplementary Figure 5G for further detail), with the position of the conserved OCT2 motif indicated. G. Change in MYC expression (qRT-PCR) in GCBME1-dependent DLBCL cell lines expressing doxycycline-inducible dCas9-KRAB after transduction with indicated sgRNAs targeting MEF2B, POU2F2, and POU2AF1 (**** p<0.0001, *** p<0.001, ** p<0.01, * p<0.01, t-test of pooled replicates for both TF gene promoter-targeting sgRNAs versus both control sgRNAs, color-coded by measured transcript per legend). H. Transcriptional reporter assay in SUDHL-5 cells for sub-regions of the GCBME-1 cloned into the <t>STARR-Seq_Ori</t> luciferase vector. Firefly luciferase signal for each sample was normalized to internal transfection control (Renilla luciferase signal) and then to the normalized signal for the no-insert control vector <t>(Ori_neg).</t> I. Transcriptional reporter assay in the indicated GCBME-1-dependent cell lines for constructs bearing the NFR 195B enhancer region, with or without OCT2 motif deletion, normalized as in H.
Starr Seq Plasmid Sequence, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ori+neg/STARR-seq+luciferase+validation+vector_ORI_neg%2Econt+(Plasmid+%2399315)/pmc06904520-374-1-11
Average 93 stars, based on 1 article reviews
starr seq plasmid sequence - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

Image Search Results


A. Heatmap showing differential acetylation of enhancer clusters with increased acetylation in GCB-DLBCL cell lines. MYC rearrangement status is coded as follows: white, no rearrangement; gray, positive for MYC::BCL6-SE rearrangement; black, positive for other MYC rearrangement. Heatmaps strips at right show significance of motif enrichment for the OCT2 and E2A ( TCF3 ) motifs in HOMER known motif analysis; black arrowheads indicate that a similar motif was identified as the most significantly enriched motif in that cluster by de novo motif analysis. See Supplementary Figures 5B-C for the corresponding data for all enhancer clusters and all cell lines. B. Western blot of nuclear extracts from GCB-DLBCL cell lines for MEF2B and CTCF (loading control). C. Genomic copy gains (log scale) for POU2AF1 in B-cell lymphoma cell lines (DepMap). GCBME-1-dependent cell lines are indicated. D. POU2F2 and POU2AF1 transcript levels in B-cell lymphoma cell lines (DepMap). GCBME-1-dependent cell lines are indicated. E. Plot of sgRNA depletion or enrichment (MAGeCK RRA log2-fold-change) for optimized gene promoter-targeting sgRNAs in lymphoma CRISPRi screens (B cell expressed transcription factors, B-cell-specific essential genes, and pan-essential genes). Target intervals are ranked along the X axis by lowest negative selection FDR p-value (left to right, intervals with log2-fold change <0) or lowest positive selection FDR p-value (right to left, intervals with log2-fold change >0). Genes with abs(log2FC) > 0.5 and fdr < 0.05 are colored blue. TF genes of interest are indicated. F. Detail of ATAC-Seq, H3K27 ChIP-Seq, and ChIP-Seq for the OCT2, OCA-B, MEF2B, and p300 in the GCBME1 enhancer cluster. CRISPRi screen NFR intervals are as indicated, with conserved subregions A and B of NFRs 195 and 196 indicated below. Inset at bottom shows further detail of the Phastcons conserved element track for sub-region 195B (see Supplementary Figure 5G for further detail), with the position of the conserved OCT2 motif indicated. G. Change in MYC expression (qRT-PCR) in GCBME1-dependent DLBCL cell lines expressing doxycycline-inducible dCas9-KRAB after transduction with indicated sgRNAs targeting MEF2B, POU2F2, and POU2AF1 (**** p<0.0001, *** p<0.001, ** p<0.01, * p<0.01, t-test of pooled replicates for both TF gene promoter-targeting sgRNAs versus both control sgRNAs, color-coded by measured transcript per legend). H. Transcriptional reporter assay in SUDHL-5 cells for sub-regions of the GCBME-1 cloned into the STARR-Seq_Ori luciferase vector. Firefly luciferase signal for each sample was normalized to internal transfection control (Renilla luciferase signal) and then to the normalized signal for the no-insert control vector (Ori_neg). I. Transcriptional reporter assay in the indicated GCBME-1-dependent cell lines for constructs bearing the NFR 195B enhancer region, with or without OCT2 motif deletion, normalized as in H.

Journal: bioRxiv

Article Title: Selective Enhancer Dependencies in MYC -Intact and MYC -Rearranged Germinal Center B-cell Diffuse Large B-cell Lymphoma

doi: 10.1101/2023.05.02.538892

Figure Lengend Snippet: A. Heatmap showing differential acetylation of enhancer clusters with increased acetylation in GCB-DLBCL cell lines. MYC rearrangement status is coded as follows: white, no rearrangement; gray, positive for MYC::BCL6-SE rearrangement; black, positive for other MYC rearrangement. Heatmaps strips at right show significance of motif enrichment for the OCT2 and E2A ( TCF3 ) motifs in HOMER known motif analysis; black arrowheads indicate that a similar motif was identified as the most significantly enriched motif in that cluster by de novo motif analysis. See Supplementary Figures 5B-C for the corresponding data for all enhancer clusters and all cell lines. B. Western blot of nuclear extracts from GCB-DLBCL cell lines for MEF2B and CTCF (loading control). C. Genomic copy gains (log scale) for POU2AF1 in B-cell lymphoma cell lines (DepMap). GCBME-1-dependent cell lines are indicated. D. POU2F2 and POU2AF1 transcript levels in B-cell lymphoma cell lines (DepMap). GCBME-1-dependent cell lines are indicated. E. Plot of sgRNA depletion or enrichment (MAGeCK RRA log2-fold-change) for optimized gene promoter-targeting sgRNAs in lymphoma CRISPRi screens (B cell expressed transcription factors, B-cell-specific essential genes, and pan-essential genes). Target intervals are ranked along the X axis by lowest negative selection FDR p-value (left to right, intervals with log2-fold change <0) or lowest positive selection FDR p-value (right to left, intervals with log2-fold change >0). Genes with abs(log2FC) > 0.5 and fdr < 0.05 are colored blue. TF genes of interest are indicated. F. Detail of ATAC-Seq, H3K27 ChIP-Seq, and ChIP-Seq for the OCT2, OCA-B, MEF2B, and p300 in the GCBME1 enhancer cluster. CRISPRi screen NFR intervals are as indicated, with conserved subregions A and B of NFRs 195 and 196 indicated below. Inset at bottom shows further detail of the Phastcons conserved element track for sub-region 195B (see Supplementary Figure 5G for further detail), with the position of the conserved OCT2 motif indicated. G. Change in MYC expression (qRT-PCR) in GCBME1-dependent DLBCL cell lines expressing doxycycline-inducible dCas9-KRAB after transduction with indicated sgRNAs targeting MEF2B, POU2F2, and POU2AF1 (**** p<0.0001, *** p<0.001, ** p<0.01, * p<0.01, t-test of pooled replicates for both TF gene promoter-targeting sgRNAs versus both control sgRNAs, color-coded by measured transcript per legend). H. Transcriptional reporter assay in SUDHL-5 cells for sub-regions of the GCBME-1 cloned into the STARR-Seq_Ori luciferase vector. Firefly luciferase signal for each sample was normalized to internal transfection control (Renilla luciferase signal) and then to the normalized signal for the no-insert control vector (Ori_neg). I. Transcriptional reporter assay in the indicated GCBME-1-dependent cell lines for constructs bearing the NFR 195B enhancer region, with or without OCT2 motif deletion, normalized as in H.

Article Snippet: Vectors ORI_SV40 (Addgene:99309) and ORI_neg.cont (Addgene: 99315) were used as positive and negative controls.

Techniques: Western Blot, Selection, ChIP-sequencing, Expressing, Quantitative RT-PCR, Transduction, Reporter Assay, Clone Assay, Luciferase, Plasmid Preparation, Transfection, Construct